Vincent T. Ho

848 total citations
27 papers, 545 citations indexed

About

Vincent T. Ho is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Vincent T. Ho has authored 27 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Vincent T. Ho's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (7 papers) and Cytomegalovirus and herpesvirus research (4 papers). Vincent T. Ho is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (7 papers) and Cytomegalovirus and herpesvirus research (4 papers). Vincent T. Ho collaborates with scholars based in United States, France and Australia. Vincent T. Ho's co-authors include Paul G. Richardson, Parisa Momtaz, Martha Wadleigh, Robert J. Soiffer, RJ Soiffer, Joseph H. Antin, Phillippe Armand, Gaia Sciaranghella, Michael P. Busch and Ann S. LaCasce and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Infectious Diseases.

In The Last Decade

Vincent T. Ho

23 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent T. Ho United States	10	221	159	118	105	85	27	545
R Cuthbert United Kingdom	14	196 0.9×	167 1.1×	126 1.1×	162 1.5×	81 1.0×	40	607
Pascual Balsalobre Spain	17	462 2.1×	70 0.4×	97 0.8×	141 1.3×	82 1.0×	57	782
Dominique Masson France	12	94 0.4×	72 0.5×	50 0.4×	215 2.0×	57 0.7×	49	470
Abhay Patki United States	11	235 1.1×	219 1.4×	129 1.1×	166 1.6×	138 1.6×	18	729
Charikleia Kelaïdi France	14	457 2.1×	44 0.3×	108 0.9×	40 0.4×	80 0.9×	45	742
Xiaoduan Weng Canada	11	39 0.2×	149 0.9×	77 0.7×	135 1.3×	48 0.6×	22	431
Gerhard Opelz Germany	16	79 0.4×	151 0.9×	49 0.4×	266 2.5×	73 0.9×	39	652
Masashi Taki Japan	15	771 3.5×	32 0.2×	44 0.4×	49 0.5×	51 0.6×	58	1.1k
Diep N. H. Tran United States	7	49 0.2×	446 2.8×	270 2.3×	322 3.1×	45 0.5×	8	883
Kalpana Bakshi United States	12	310 1.4×	64 0.4×	88 0.7×	19 0.2×	27 0.3×	28	448

Countries citing papers authored by Vincent T. Ho

Since Specialization

Citations

This map shows the geographic impact of Vincent T. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent T. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent T. Ho more than expected).

Fields of papers citing papers by Vincent T. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent T. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent T. Ho. The network helps show where Vincent T. Ho may publish in the future.

Co-authorship network of co-authors of Vincent T. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent T. Ho. A scholar is included among the top collaborators of Vincent T. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent T. Ho. Vincent T. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chatterjee, Anjan, et al.. (2025). Exploring the effects of faecal microbiota transplantation on cognitive function: A review of clinical trials. Brain Behavior & Immunity - Health. 48. 101049–101049. 3 indexed citations

Murdock, H. Moses, Kyle Hebert, Edoardo Auriemma, et al.. (2025). Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML. Blood. 146(Supplement 1). 4206–4206.

Little, Jessica S, Rémy Duléry, Roman M. Shapiro, et al.. (2023). Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft. Transplantation and Cellular Therapy. 30(2). 233.e1–233.e14. 5 indexed citations

Putta, Santosh, Bradford A. Young, John E. Levine, et al.. (2022). Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy. 29(3). 166.e1–166.e10. 4 indexed citations

Maurer, Katie, Haesook T. Kim, Carol Reynolds, et al.. (2022). Allogeneic Stem Cell Cryopreservation Is Associated with Equivalent Survival and Relapse Rates with Lower Rate of Severe Chronic Gvhd. Blood. 140(Supplement 1). 4804–4805. 1 indexed citations

Baumrin, Emily, Matthew P. Cheng, Sanjat Kanjilal, et al.. (2019). Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis. Biology of Blood and Marrow Transplantation. 25(8). 1642–1647. 10 indexed citations

Kernan, Nancy A., Stephan A. Grupp, Angela R. Smith, et al.. (2018). Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome. British Journal of Haematology. 181(6). 816–827. 89 indexed citations

Nikiforow, Sarah, H. T. Kim, Heather Daley, et al.. (2016). A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation. Haematologica. 101(10). 1251–1259. 26 indexed citations

Williams, Kirsten M., Guang‐Shing Cheng, Iskra Pusic, et al.. (2015). Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(2). S61–S62. 1 indexed citations

10.

Murase, Kazuyuki, H. T. Kim, Yutaka Kawano, et al.. (2014). Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. Haematologica. 99(9). 1499–1508. 16 indexed citations

11.

Henrich, Timothy J., Zixin Hu, Gaia Sciaranghella, et al.. (2013). Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation. The Journal of Infectious Diseases. 207(11). 1694–1702. 182 indexed citations

12.

Gazourian, Lee, Angela J. Rogers, Gerald L. Weinhouse, et al.. (2012). Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Respiratory Medicine. 107(2). 276–283. 12 indexed citations

13.

Richardson, PG, Vincent T. Ho, Corey Cutler, et al.. (2012). Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Novel Insights to Pathogenesis, Current Status of Treatment, and Future Directions. Biology of Blood and Marrow Transplantation. 19(1). S88–S90. 29 indexed citations

14.

Richardson, Paul G., Selim Corbacioglu, Vincent T. Ho, et al.. (2012). Drug safety evaluation of defibrotide. Expert Opinion on Drug Safety. 12(1). 123–136. 59 indexed citations

15.

Richardson, Paul G., Erica Linden, Carolyn Revta, & Vincent T. Ho. (2009). Use of defibrotide in the treatment and prevention of veno-occlusive disease. Expert Review of Hematology. 2(4). 365–376. 10 indexed citations

16.

Ho, Vincent T., Glenn Dranoff, Mildred Pasek, et al.. (2007). 59: GM-CSF secreting leukemia cell vaccinations after allogeneic reduced-intensity peripheral blood stem cell transplantation (SCT) for advanced myelodysplastic syndrome (MDS) or refractory acute myeloid leukemia (AML). Biology of Blood and Marrow Transplantation. 13(2). 24–24. 3 indexed citations

17.

Ho, Vincent T., Glenn Dranoff, Mildred Pasek, et al.. (2006). GM-CSF secreting leukemia cell vaccinations after allogeneic non-myeloablative peripheral blood stem cell transplantation in patients with advanced myelodysplastic syndrome or refractory acute myeloid leukemia. Biology of Blood and Marrow Transplantation. 12(2). 17–18. 1 indexed citations

18.

Cutler, Corey, N. Lynn Henry, Ciara N. Magee, et al.. (2005). Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation. 11(2). 4–4. 1 indexed citations

19.

Cutler, Corey, et al.. (2005). Sirolimus and tacrolimus as graft-versus-host disease prophylaxis in allogeneic stem cell transplantation: The Dana Farber Cancer Institute experience. Biology of Blood and Marrow Transplantation. 11(2). 3–4. 2 indexed citations

20.

Wadleigh, Martha, Vincent T. Ho, Parisa Momtaz, & Paul G. Richardson. (2003). Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Current Opinion in Hematology. 10(6). 451–462. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact